OpenVSafe by OpenVAERS
Search V-safe

7U4-18534-57998

3 vaccinations 9 coded responses 27 check-ins 9 free-text entries 2 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
984 / WA
Registered
2021-03-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-25
    Registered in v-safe
  3. 2021-03-25
    Survey response — day 7, dose 1
    MedDRA: Haematochezia — Feeling: Good
    Free text: Blood in stool for first few days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-31
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-04-07
    Survey response — day 21, dose 1
    MedDRA: Localised infection, Peripheral swelling, Pruritus, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Foot infection - swollen and itchy · Healthcare visit (other): Appt tomorrow
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-07
    Report sent to call center — day 21, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-04-14
    Dose 2 — Pfizer-BioNTech
  8. 2021-04-14
    Health check-in — day 0, dose 2
    Feeling: Fair · Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Adult check-in
  9. 2021-04-14
    Report sent to call center — day 0, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  11. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  12. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  13. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-04-23
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-05-05
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-05-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-07-16
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-12-02
    Dose 3 — Moderna
  21. 2021-12-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  22. 2021-12-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  23. 2021-12-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-12-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2021-12-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Rash, not including the immediate area around the injection site
    Adult check-in
  26. 2021-12-16
    Survey response — day 14, dose 3
    MedDRA: Rash, Urticaria — Feeling: Fair
    Free text: Rash and hives on feet, legs, hands, wrists, neck
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-12-23
    Survey response — day 21, dose 3
    MedDRA: Skin disorder — Feeling: Good · Be unable to do your normal daily activities
    Free text: More skin issues this time on my toes
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-12-30
    Survey response — day 28, dose 3
    MedDRA: Condition aggravated, Pain, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Toe issues have worsened - painful to walk l
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-01-06
    Survey response — day 35, dose 3
    MedDRA: Rash, Rash pruritic, Rash vesicular, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Feet and rash worsening. Itchy blistering bumps on palms and all over body
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-01-13
    Survey response — day 42, dose 3
    MedDRA: Fatigue, Headache, Pruritus, Skin disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Skin issues continuing - itch patches on hands feet mainly. Some headaches and tiredness too
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-03-03
    Survey response — 3 months, dose 3
    MedDRA: Headache, Skin disorder — Feeling: Fair
    Free text: New or worse than of the Skin conditions. Some headaches.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-03-25
  33. 2022-06-04
    Survey response — 6 months, dose 3
    MedDRA: Migraine — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Migraine
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-12-02
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Pfizer-BioNTech
22021-04-14Pfizer-BioNTech
32021-12-02Moderna No

Call center

2 call center cases

2 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 6 — day 7, dose 1

2021-03-25

Systemic reaction (other): Blood in stool for first few days

Release 7 — day 21, dose 1

2021-04-07

Symptoms: Foot infection - swollen and itchy
Healthcare visit (other): Appt tomorrow

Release 10 — day 14, dose 3

2021-12-16

Symptoms: Rash and hives on feet, legs, hands, wrists, neck

Release 10 — day 21, dose 3

2021-12-23

Symptoms: More skin issues this time on my toes

Release 10 — day 28, dose 3

2021-12-30

Symptoms: Toe issues have worsened - painful to walk l

Release 10 — day 35, dose 3

2022-01-06

Symptoms: Feet and rash worsening. Itchy blistering bumps on palms and all over body

Release 10 — day 42, dose 3

2022-01-13

Symptoms: Skin issues continuing - itch patches on hands feet mainly. Some headaches and tiredness too

Release 11 — 3 months, dose 3

2022-03-03

Symptoms: New or worse than of the Skin conditions. Some headaches.

Release 11 — 6 months, dose 3

2022-06-04

Symptoms: Migraine

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDCondition aggravated · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDLocalised infection ✓ ✓ ✓
SDMigraine · · ✓
SDPain · · ✓
SDPeripheral swelling ✓ ✓ ✓
SDPre-existing disease · · ✓
SDPruritus ✓ ✓ ✓
SDRash · · ✓
SDRash pruritic · · ✓
SDRash vesicular · · ✓
SDSkin disorder · · ✓
SDUnevaluable event · · ✓
SDUrticaria · · ✓
SROHaematochezia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release